MARK S CHAMBERS

TitleProfessor
InstitutionMD Anderson
DepartmentHead & Neck Surgery
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Lu C, Goepfert RP, Fuller CD, Lai SY, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete S. Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer. 2021 Dec 01; 127(23):4470-4480. PMID: 34358341.
      Citations:    Fields:    
    2. Gunn GB, Garden AS, Ye R, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ. Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience. Int J Part Ther. 2021; 8(1):108-118. PMID: 34285940.
      Citations:    
    3. Alqarni H, Montgomery P, Aponte-Wesson R, Won AM, Hofstede TM, Chambers MS. Combined rehabilitation of a lower lip defect after resection of floor of mouth cancer: A clinical report. J Prosthet Dent. 2021 Apr 15. PMID: 33867164.
      Citations:    Fields:    
    4. Lugar CW, Clarke CA, Morphy R, Rudyk H, Sapmaz S, Stites RE, Vaught GM, Furness K, Broughton HB, Durst GL, Clawson DK, Stout SL, Guo SY, Durbin JD, Stayrook KR, Edmondson DD, Kikly K, New NE, Bina HA, Chambers MG, Shetler P, Chang WY, Chang VC, Barr R, Gough WH, Steele JP, Getman B, Patel N, Mathes BM, Richardson TI. Defining Target Engagement Required for Efficacy In Vivo at the Retinoic Acid Receptor-Related Orphan Receptor C2 (ROR?t). J Med Chem. 2021 05 13; 64(9):5470-5484. PMID: 33852312.
      Citations:    Fields:    Translation:HumansAnimalsCells
    5. Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Granberry RC, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed ASR, Fuller CD, Lai SY, Rao A. Computed Tomography Radiomics Kinetics as Early Imaging Correlates of Osteoradionecrosis in Oropharyngeal Cancer Patients. Front Artif Intell. 2021; 4:618469. PMID: 33898983.
      Citations:    
    6. Srivastava A, Chambers MS, Aponte-Wesson R. Bilabial-protruding, mouth-opening and tongue-depressing stent for proton radiation therapy. J Prosthet Dent. 2021 Apr 01. PMID: 33814095.
      Citations:    Fields:    
    7. Aponte-Wesson R, Knott J, Montgomery P, Chambers MS. Floor of mouth prosthesis with removable depressible tongue: A clinical report. J Prosthet Dent. 2021 Feb 16. PMID: 33608105.
      Citations:    Fields:    
    8. Cardoso RC, Kamal M, Zaveri J, Chambers MS, Gunn GB, Fuller CD, Lai SY, Mott FE, McMillan H, Hutcheson KA. Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center. Support Care Cancer. 2021 Apr; 29(4):1825-1835. PMID: 32779007.
      Citations:    Fields:    Translation:Humans
    9. Mohamed ASR, He R, Ding Y, Wang J, Fahim J, Elgohari B, Elhalawani H, Kim AD, Ahmed H, Garcia JA, Johnson JM, Stafford RJ, Bankson JA, Chambers MS, Sandulache VC, Fuller CD, Lai SY. Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1319-1328. PMID: 32712257.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Zaid M, Koay EJ, Bajaj N, Mathew R, Xiao L, Agrawal A, Fernandes P, Burrows H, Roach MA, Wilke CT, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol. 2020 07; 106:104665. PMID: 32298994.
      Citations:    Fields:    Translation:Humans
    11. Srivastava A, Al-Zubidi N, Appelbaum E, Gombos DS, Nader ME, Gidley PW, Chambers MS. Immune-Related Oral, Otologic, and Ocular Adverse Events. Adv Exp Med Biol. 2020; 1244:295-307. PMID: 32301024.
      Citations: 2     Fields:    Translation:Humans
    12. Garcia MK, Meng Z, Rosenthal DI, Shen Y, Chambers M, Yang P, Wei Q, Hu C, Wu C, Bei W, Prinsloo S, Chiang J, Lopez G, Cohen L. Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2019 12 02; 2(12):e1916910. PMID: 31808921.
      Citations: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    13. Zaid M, Bajaj N, Burrows H, Mathew R, Dai A, Wilke CT, Palasi S, Hergenrother R, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS, Koay EJ. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol. 2019 Aug 19; 14(1):148. PMID: 31426824.
      Citations: 4     Fields:    Translation:Humans
    14. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269. PMID: 31037378.
      Citations: 2     Fields:    Translation:Humans
    15. Aponte-Wesson R, Khadivi AA, Cardoso R, Chambers MS. An alternative impression technique for capturing anatomic undercuts to rehabilitate a patient with a total maxillectomy: A clinical report. J Prosthet Dent. 2019 Oct; 122(4):412-416. PMID: 30982617.
      Citations:    Fields:    Translation:Humans
    16. Wang JK, Montgomery PC, Chambers MS. A custom positioning aid for an auricular prosthesis: A clinical report. J Prosthet Dent. 2018 Oct; 120(4):624-627. PMID: 29961616.
      Citations:    Fields:    Translation:Humans
    17. Won AM, Boddu P, Otun AO, Aponte-Wesson R, Chambers M. Chronic myelogenous leukemia presenting with osteonecrosis of the jaw as a rare but debilitating toxicity of dasatinib: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Oct; 126(4):e208-e211. PMID: 29941400.
      Citations:    Fields:    Translation:Humans
    18. Chambers MS, Rugo HS, Litton JK, Meiller TF. Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer. J Am Dent Assoc. 2018 04; 149(4):291-298. PMID: 29439772.
      Citations: 3     Fields:    Translation:Humans
    19. Schiodt M, Vadhan-Raj S, Chambers MS, Nicolatou-Galitis O, Politis C, Coropciuc R, Fedele S, Jandial D, Zhang J, Ma H, Saunders DP. A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Support Care Cancer. 2018 Jun; 26(6):1905-1915. PMID: 29275525.
      Citations: 12     Fields:    Translation:Humans
    20. Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Al Feghali KA, Meheissen MAM, Eraj SA, Dursteler AE, Williams B, Smith JB, Aymard JM, Berends J, White AL, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Lu C, Mohamed ASR, Fuller CD, Gunn GB. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80. PMID: 29229507.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    21. Wilke CT, Zaid M, Chung C, Fuller CD, Mohamed ASR, Skinner H, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Chambers MS, Koay EJ. Design and fabrication of a 3D-printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Print Med. 2017; 3(1):12. PMID: 29782600.
      Citations: 9     
    22. Boddu P, Chen PL, Nagarajan P, Prieto VG, Won A, Chambers M, Kornblau S. Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure. J Oral Maxillofac Surg Med Pathol. 2018 Jan; 30(1):50-54. PMID: 29404266.
      Citations:    
    23. Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One. 2017; 12(7):e0180396. PMID: 28678827.
      Citations: 2     Fields:    Translation:Humans
    24. Durham TB, Marimuthu J, Toth JL, Liu C, Adams L, Mudra DR, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR. A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose. J Med Chem. 2017 07 13; 60(13):5933-5939. PMID: 28613895.
      Citations: 3     Fields:    Translation:HumansAnimals
    25. Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol. 2017 06; 123(3):401-405. PMID: 28549794.
      Citations: 13     Fields:    Translation:Humans
    26. Chandrasekhar S, Yu XP, Harvey AK, Oskins JL, Lin C, Wang X, Blanco MJ, Fisher MJ, Kuklish SL, Schiffler MA, Vetman T, Warshawsky AM, York JS, Bendele AM, Chambers MG. Analgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonists. Pharmacol Res Perspect. 2017 06; 5(3):e00316. PMID: 28603634.
      Citations: 2     Fields:    
    27. Reyes-Gibby CC, Melkonian SC, Hanna EY, Yeung SJ, Lu C, Chambers MS, Banala SR, Gunn GB, Shete SS. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. 2017 06; 39(6):1195-1204. PMID: 28346771.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    28. Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK. Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. Lancet Oncol. 2017 05; 18(5):654-662. PMID: 28314691.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    29. Wong ATT, Lai SY, Gunn GB, Beadle BM, Fuller CD, Barrow MP, Hofstede TM, Chambers MS, Sturgis EM, Mohamed ASR, Lewin JS, Hutcheson KA. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. Oral Oncol. 2017 03; 66:75-80. PMID: 28249651.
      Citations: 8     Fields:    Translation:Humans
    30. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27479341.
      Citations:    Fields:    Translation:Humans
    31. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27400694.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    32. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27544974.
      Citations:    Fields:    Translation:Humans
    33. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27660691.
      Citations: 8     
    34. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26764191.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    35. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 2132558.
      Citations: 20     Fields:    Translation:Humans
    36. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 5797386.
      Citations:    Fields:    Translation:HumansAnimals
    37. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 5787654.
      Citations:    Fields:    Translation:Humans
    38. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23795771.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    39. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16012251.
      Citations: 10     Fields:    Translation:Humans
    40. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14967419.
      Citations: 33     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    41. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 7722933.
      Citations:    Fields:    Translation:Humans
    42. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24385339.
      Citations: 3     Fields:    Translation:Humans
    43. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24954065.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    44. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15617317.
      Citations: 3     Fields:    Translation:Humans
    45. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16797470.
      Citations: 13     Fields:    Translation:Animals
    46. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12869978.
      Citations: 5     Fields:    Translation:Humans
    47. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17022299.
      Citations:    Fields:    Translation:Humans
    48. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16798063.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    49. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17379432.
      Citations: 15     Fields:    Translation:Humans
    50. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19572386.
      Citations: 12     Fields:    Translation:Humans
    51. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18455324.
      Citations: 50     Fields:    Translation:HumansPHPublic Health
    52. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20552094.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    53. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12942062.
      Citations: 4     Fields:    
    54. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11807492.
      Citations:    Fields:    Translation:Humans
    55. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16543024.
      Citations: 17     Fields:    Translation:Humans
    56. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19853175.
      Citations: 2     Fields:    Translation:Humans
    57. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21231864.
      Citations: 1     Fields:    Translation:Humans
    58. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23763786.
      Citations: 3     Fields:    
    59. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27881320.
      Citations: 2     Fields:    Translation:Humans
    60. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30859653.
      Citations: 2     Fields:    Translation:Humans
    61. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32342541.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    62. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32533621.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    63. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32642950.
      Citations:    Fields:    Translation:HumansPHPublic Health
    64. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32888342.
      Citations: 1     Fields:    Translation:Humans
    65. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33190182.
      Citations: 3     Fields:    Translation:Humans
    66. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33489162.
      Citations:    
    67. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34430717.
      Citations:    
    68. Won AM, Montgomery P, Aponte-Wesson R, Chambers M. Implant-supported and magnet-retained oral-nasal combination prosthesis in a patient with a total rhinectomy and partial maxillectomy due to cancer: A clinical report. J Prosthet Dent. 2017 Feb; 117(2):315-320. PMID: 27666495.
      Citations: 2     Fields:    Translation:Humans
    69. Artopoulou II, Chambers MS, Eliades G. Porosity of maxillofacial silicone elastomers and microleakage pattern of the commercially pure Ti-silicone elastomer interface after hydrothermal cycling. J Prosthet Dent. 2016 Dec; 116(6):937-942. PMID: 27460319.
      Citations:    Fields:    Translation:Humans
    70. Wiley MR, Durham TB, Adams LA, Chambers MG, Lin C, Liu C, Marimuthu J, Mitchell PG, Mudra DR, Swearingen CA, Toth JL, Weller JM, Thirunavukkarasu K. Use of Osmotic Pumps to Establish the Pharmacokinetic-Pharmacodynamic Relationship and Define Desirable Human Performance Characteristics for Aggrecanase Inhibitors. J Med Chem. 2016 06 23; 59(12):5810-22. PMID: 27194201.
      Citations:    Fields:    Translation:HumansAnimalsCells
    71. Hughes NE, Bleisch TJ, Jones SA, Richardson TI, Doti RA, Wang Y, Stout SL, Durst GL, Chambers MG, Oskins JL, Lin C, Adams LA, Page TJ, Barr RJ, Zink RW, Osborne H, Montrose-Rafizadeh C, Norman BH. Identification of potent and selective retinoic acid receptor gamma (RAR?) antagonists for the treatment of osteoarthritis pain using structure based drug design. Bioorg Med Chem Lett. 2016 07 15; 26(14):3274-3277. PMID: 27261179.
      Citations: 1     Fields:    Translation:HumansCells
    72. Artopoulou II, Chambers MS, Zinelis S, Eliades G. Peel strength and interfacial characterization of maxillofacial silicone elastomers bonded to titanium. Dent Mater. 2016 07; 32(7):e137-47. PMID: 27118682.
      Citations:    Fields:    Translation:Humans
    73. Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol. 2016 06; 57:1-5. PMID: 27208837.
      Citations: 3     Fields:    Translation:Humans
    74. Blanco MJ, Vetman T, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Chambers M, Lin C, Mudra D, Oskins J, Wang XS, Yu XP, Warshawsky AM. Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists. Bioorg Med Chem Lett. 2016 May 01; 26(9):2303-7. PMID: 27020304.
      Citations: 4     Fields:    Translation:AnimalsCells
    75. Chandrasekhar S, Harvey AK, Yu XP, Chambers MG, Oskins JL, Lin C, Seng TW, Thibodeaux SJ, Norman BH, Hughes NE, Schiffler MA, Fisher MJ. Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia. J Pharmacol Exp Ther. 2016 Mar; 356(3):635-44. PMID: 26740668.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    76. Grant SR, Grosshans DR, Bilton SD, Garcia JA, Amin M, Chambers MS, McGovern SL, McAleer MF, Morrison WH, Huh WW, Kupferman ME, Mahajan A. Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics. Radiother Oncol. 2015 Aug; 116(2):309-15. PMID: 26232128.
      Citations: 9     Fields:    Translation:Humans
    77. Ch'ng S, Skoracki RJ, Selber JC, Yu P, Martin JW, Hofstede TM, Chambers MS, Liu J, Hanasono MM. Osseointegrated implant-based dental rehabilitation in head and neck reconstruction patients. Head Neck. 2016 04; 38 Suppl 1:E321-7. PMID: 25546139.
      Citations: 12     Fields:    Translation:Humans
    78. Bhayani MK, Acharya V, Kongkiatkamon S, Farah S, Roberts DB, Sterba J, Chambers MS, Lai SY. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia. Thyroid. 2015 Jul; 25(7):834-8. PMID: 25860842.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    79. Acharya V, Chambers MS. Maxillofacial prosthodontic rehabilitation of a patient with oral complications during and after multimodality therapy for the management of oral squamous cell carcinoma. J Prosthet Dent. 2015 Jun; 113(6):651-5. PMID: 25858211.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    80. Durham TB, Klimkowski VJ, Rito CJ, Marimuthu J, Toth JL, Liu C, Durbin JD, Stout SL, Adams L, Swearingen C, Lin C, Chambers MG, Thirunavukkarasu K, Wiley MR. Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis. J Med Chem. 2014 Dec 26; 57(24):10476-85. PMID: 25415648.
      Citations: 6     Fields:    Translation:AnimalsCells
    81. Guidetti R, Astles PC, Sanderson AJ, Hollinshead SP, Johnson MP, Chambers MG. The SAR development of substituted purine derivatives as selective CB2 agonists for the treatment of chronic pain. Bioorg Med Chem Lett. 2014 Dec 15; 24(24):5572-5575. PMID: 25466177.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    82. Cardoso RC, Gerngross PJ, Hofstede TM, Weber DM, Chambers MS. The multiple oral presentations of multiple myeloma. Support Care Cancer. 2014 Jan; 22(1):259-67. PMID: 24048519.
      Citations: 6     Fields:    Translation:Humans
    83. Beadle BM, Liao KP, Chambers MS, Elting LS, Buchholz TA, Kian Ang K, Garden AS, Guadagnolo BA. Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: a SEER-Medicare analysis. Head Neck. 2013 Nov; 35(11):1599-605. PMID: 23150453.
      Citations: 13     Fields:    Translation:Humans
    84. Lewin JS, Hutcheson KA, Barringer DA, Croegaert LE, Lisec A, Chambers MS. Customization of the voice prosthesis to prevent leakage from the enlarged tracheoesophageal puncture: results of a prospective trial. Laryngoscope. 2012 Aug; 122(8):1767-72. PMID: 22753122.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    85. Hollinshead SP, Astles PC, Chambers MG, Johnson MP, Palmer J, Tidwell MW. Discovery and optimization of novel purines as potent and selective CB2 agonists. Bioorg Med Chem Lett. 2012 Aug 01; 22(15):4962-6. PMID: 22765893.
      Citations: 1     Fields:    Translation:HumansAnimals
    86. Ahmed A, Chambers MS, Goldschmidt MC, Habib A, Lei X, Jacob RF. Association between microbial flora and tissue abnormality around dental implants penetrating the skin in reconstructed oral cancer patients. Int J Oral Maxillofac Implants. 2012 May-Jun; 27(3):684-94. PMID: 22616064.
      Citations: 1     Fields:    Translation:Humans
    87. Meng Z, Kay Garcia M, Hu C, Chiang J, Chambers M, Rosenthal DI, Peng H, Wu C, Zhao Q, Zhao G, Liu L, Spelman A, Lynn Palmer J, Wei Q, Cohen L. Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Eur J Cancer. 2012 Jul; 48(11):1692-9. PMID: 22285177.
      Citations: 13     Fields:    Translation:Humans
    88. Lewis CM, Glisson BS, Feng L, Wan F, Tang X, Wistuba II, El-Naggar AK, Rosenthal DI, Chambers MS, Lustig RA, Weber RS. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Mar 01; 18(5):1435-46. PMID: 22261807.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    89. Witsell DL, Stinnett S, Chambers MS. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Head Neck. 2012 Aug; 34(8):1136-42. PMID: 22231734.
      Citations: 4     Fields:    Translation:Humans
    90. Schwartz DL, Garden AS, Thomas J, Chen Y, Zhang Y, Lewin J, Chambers MS, Dong L. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):986-93. PMID: 22138459.
      Citations: 68     Fields:    Translation:HumansCTClinical Trials
    91. Meng Z, Garcia MK, Hu C, Chiang J, Chambers M, Rosenthal DI, Peng H, Zhang Y, Zhao Q, Zhao G, Liu L, Spelman A, Palmer JL, Wei Q, Cohen L. Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer. 2012 Jul 01; 118(13):3337-44. PMID: 22072272.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    92. Bidra AS, Tarrand JJ, Roberts DB, Rolston KV, Chambers MS. Antimicrobial efficacy of oral topical agents on microorganisms associated with radiated head and neck cancer patients: an in vitro study. Quintessence Int. 2011 Apr; 42(4):307-15. PMID: 21516276.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    93. Schuelert N, Johnson MP, Oskins JL, Jassal K, Chambers MG, McDougall JJ. Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis. Pain. 2011 May; 152(5):975-981. PMID: 21185649.
      Citations: 27     Fields:    Translation:AnimalsCells
    94. Artopoulou II, Powers JM, Chambers MS. In vitro staining effects of stannous fluoride and sodium fluoride on ceramic material. J Prosthet Dent. 2010 Mar; 103(3):163-9. PMID: 20188238.
      Citations: 3     Fields:    
    95. Garcia MK, Chiang JS, Cohen L, Liu M, Palmer JL, Rosenthal DI, Wei Q, Tung S, Wang C, Rahlfs T, Chambers MS. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck. 2009 Oct; 31(10):1360-8. PMID: 19378325.
      Citations: 13     Fields:    Translation:Humans
    96. Oh HK, Chambers MS, Martin JW, Lim HJ, Park HJ. Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis. J Oral Maxillofac Surg. 2009 Jul; 67(7):1378-86. PMID: 19531406.
      Citations: 20     Fields:    Translation:Humans
    97. Chambers MS, Tomsett KL, Artopoulou II, Garden AS, El-Naggar AK, Martin JW, Keene HJ. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation. J Prosthet Dent. 2008 Aug; 100(2):142-6. PMID: 18672129.
      Citations: 4     Fields:    Translation:Humans
    98. Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessell AC, Lewin JS, Ang KK, Kies MS, Gning I, Wang XS, Cleeland CS. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61. PMID: 18501527.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    99. Gerngross PJ, Chambers MS, Martin JW. Oral rehabilitation of a mandibular discontinuity defect: a clinical report. Tex Dent J. 2008 May; 125(5):438-41. PMID: 18561799.
      Citations:    Fields:    Translation:Humans
    100. Elting LS, Avritscher EB, Cooksley CD, Cardenas-Turanzas M, Garden AS, Chambers MS. Psychosocial and economic impact of cancer. Dent Clin North Am. 2008 Jan; 52(1):231-52, x. PMID: 18154872.
      Citations: 2     Fields:    Translation:Humans
    101. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, S Wang X, Cleeland CS. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31. PMID: 17358040.
      Citations: 68     Fields:    Translation:Humans
    102. Carter QL, Dotzlaf J, Swearingen C, Brittain I, Chambers M, Duffin K, Mitchell P, Thirunavukkarasu K. Development and characterization of a novel ELISA based assay for the quantitation of sub-nanomolar levels of neoepitope exposed NITEGE-containing aggrecan fragments. J Immunol Methods. 2007 Dec 01; 328(1-2):162-8. PMID: 17942111.
      Citations: 2     Fields:    Translation:HumansAnimals
    103. Chambers MS, Jones CU, Biel MA, Weber RS, Hodge KM, Chen Y, Holland JM, Ship JA, Vitti R, Armstrong I, Garden AS, Haddad R. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1369-76. PMID: 17855005.
      Citations: 11     Fields:    Translation:Humans
    104. Garden AS, Chambers MS. Head and neck radiation and mucositis. Curr Opin Support Palliat Care. 2007 Apr; 1(1):30-4. PMID: 18660721.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    105. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1110-20. PMID: 17398022.
      Citations: 103     Fields:    Translation:HumansPHPublic Health
    106. Ohshiro K, Rosenthal DI, Koomen JM, Streckfus CF, Chambers M, Kobayashi R, El-Naggar AK. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol. 2007 Mar; 30(3):743-9. PMID: 17273777.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    107. Chambers MS, Rosenthal DI, Weber RS. Radiation-induced xerostomia. Head Neck. 2007 Jan; 29(1):58-63. PMID: 16906511.
      Citations: 19     Fields:    Translation:HumansAnimals
    108. Chambers MS, Fleming TJ, Toth BB, Lemon JC, Craven TE, Bouwsma OJ, Garden AS, Espeland MA, Keene HJ, Martin JW, Sipos T. Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study". Oral Oncol. 2007 Jan; 43(1):98-105. PMID: 18027401.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    109. Zhang Y, Zhang L, Zhu XR, Lee AK, Chambers M, Dong L. Reducing metal artifacts in cone-beam CT images by preprocessing projection data. Int J Radiat Oncol Biol Phys. 2007 Mar 01; 67(3):924-32. PMID: 17161556.
      Citations: 46     Fields:    Translation:Humans
    110. Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T, Fleming TJ. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides. Oral Oncol. 2006 Oct; 42(9):934-45. PMID: 16891149.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    111. Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T, Fleming TJ. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study. Oral Oncol. 2006 Oct; 42(9):946-53. PMID: 16757200.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    112. Gillenwater AM, Chambers MS. Diagnosis of premalignant lesions and early cancers of the oral cavity. Tex Dent J. 2006 Jun; 123(6):512-20. PMID: 16875018.
      Citations:    Fields:    Translation:Humans
    113. Artopoulou II, Lemon JC, Clayman GL, Chambers MS. Stent fabrication for graft immobilization following wide surgical excision of myofibroblastic sarcoma of the buccal mucosa: a clinical report. J Prosthet Dent. 2006 Apr; 95(4):280-5. PMID: 16616124.
      Citations: 5     Fields:    Translation:Humans
    114. Zhang L, Garden AS, Lo J, Ang KK, Ahamad A, Morrison WH, Rosenthal DI, Chambers MS, Zhu XR, Mohan R, Dong L. Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Apr 01; 64(5):1559-69. PMID: 16580505.
      Citations: 46     Fields:    Translation:Humans
    115. Garden AS, Lewin JS, Chambers MS. How to reduce radiation-related toxicity in patients with cancer of the head and neck. Curr Oncol Rep. 2006 Mar; 8(2):140-5. PMID: 16507224.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    116. Gerngross PJ, Martin CD, Ball JD, Engelmeier RL, Gilbert HD, Powers JM, Narendran S, Chambers MS. Period between completion of radiation therapy and prosthetic rehabilitation in edentulous patients: a retrospective study. J Prosthodont. 2005 Jun; 14(2):110-21. PMID: 16011622.
      Citations:    Fields:    Translation:Humans
    117. Tomsett KL, Chambers MS, Martin JW, Gillenwater AM, Lemon JC. A technique for the fabrication of an immediate mandibular surgical stent securing a skin graft. J Prosthet Dent. 2005 Apr; 93(4):395-7. PMID: 15798691.
      Citations: 1     Fields:    Translation:Humans
    118. Chambers MS, Garden AS, Rosenthal D, Ahamad A, Schwartz DL, Blanco AI, Chao KS, Morrison WH, Ang KK, Weber RS. Intensity-modulated radiotherapy: is xerostomia still prevalent? Curr Oncol Rep. 2005 Mar; 7(2):131-6. PMID: 15717947.
      Citations: 7     Fields:    Translation:Humans
    119. Chambers MS, Keene HJ, Toth BB, Lemon JC, Gallagher SC, Martin CG, Martin JW. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Feb; 99(2):180-4. PMID: 15660089.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    120. Martin JW, Tselios N, Chambers MS. Treatment strategy for patients with ectodermal dysplasia: a case report. J Clin Pediatr Dent. 2005; 29(2):113-8. PMID: 15719913.
      Citations:    Fields:    Translation:Humans
    121. Artopoulou II, Higuera S, Martin JW, Stal S, Chambers MS. Postsurgical use of prosthetic palatal appliances. Two case reports. J Clin Pediatr Dent. 2005; 30(2):105-8. PMID: 16491962.
      Citations:    Fields:    Translation:Humans
    122. Rosenthal DI, Chambers MS, Weber RS, Eisbruch A. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Semin Oncol. 2004 Dec; 31(6 Suppl 18):25-8. PMID: 15726519.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    123. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004 Sep; 26(9):796-807. PMID: 15350026.
      Citations: 60     Fields:    Translation:Humans
    124. Lemon JC, Brignoni RA, Collard SM, Martin JW, Powers JM, Chambers MS. In vitro effect of microwave irradiation on the retentive force of magnets. J Prosthet Dent. 2004 Apr; 91(4):368-73. PMID: 15116039.
      Citations: 1     Fields:    
    125. Oh HK, Chambers MS, Garden AS, Wong PF, Martin JW. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg. 2004 Feb; 62(2):139-44. PMID: 14762744.
      Citations: 12     Fields:    Translation:Humans
    126. Chambers MS, Lemon JC, Martin JW. Obturation of the partial soft palate defect. J Prosthet Dent. 2004 Jan; 91(1):75-9. PMID: 14739897.
      Citations: 2     Fields:    Translation:Humans
    127. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003 Oct 01; 98(7):1531-9. PMID: 14508842.
      Citations: 144     Fields:    Translation:Humans
    128. Lemon JC, Lewin JS, Martin JW, Chambers MS. Custom modification of the Blom-Singer tracheostoma valve housing. J Prosthodont. 2003 Mar; 12(1):17-20. PMID: 12677607.
      Citations: 1     Fields:    Translation:Humans
    129. Chambers MS. Clinical commentary on prophylactic treatment of radiation-induced xerostomia. Arch Otolaryngol Head Neck Surg. 2003 Feb; 129(2):251-2. PMID: 12578461.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    130. Chambers MS, Lemon JC, Martin JW. How I do it: a technique for oral wound irrigation following maxillectomy and mandibulectomy. ORL Head Neck Nurs. 2003; 21(4):27-8. PMID: 14621658.
      Citations:    Fields:    Translation:Humans
    131. Lemon JC, Chambers MS. Locking retentive attachment for an implant-retained auricular prosthesis. J Prosthet Dent. 2002 Mar; 87(3):336-8. PMID: 11941364.
      Citations: 8     Fields:    Translation:Humans
    132. Lemon JC, Lewin JS, Chambers MS, Martin JW. Modification of the Barton button for tracheoesophageal speech: an innovative maxillofacial prosthetic technique. J Prosthet Dent. 2002 Feb; 87(2):236-9. PMID: 11854684.
      Citations: 2     Fields:    Translation:Humans
    133. Chambers MS, Rassekn CH, Toth BB, Lemon JC, Hoffman RD. A maxillary fibro-osseous lesion: differential diagnosis and case report. Tex Dent J. 2002 Jan; 119(1):12-9. PMID: 11887508.
      Citations: 3     Fields:    Translation:Humans
    134. Toth BB, Martin JW, Chambers MS, Robinson KA, Andersson BS. Oral candidiasis: a morbid sequela of anticancer therapy. Tex Dent J. 1998 Jun; 115(6):24-9. PMID: 9667209.
      Citations: 1     Fields:    Translation:Humans
    135. Lemon JC, Chambers MS, Martin JW. Prosthetic rehabilitation of patients with advanced nonmelanoma skin cancer. Clin Plast Surg. 1997 Oct; 24(4):797-815. PMID: 9342516.
      Citations:    Fields:    Translation:Humans
    136. Mazzuca SA, Brandt KD, Katz BP, Chambers M, Byrd D, Hanna M. Effects of self-care education on the health status of inner-city patients with osteoarthritis of the knee. Arthritis Rheum. 1997 Aug; 40(8):1466-74. PMID: 9259427.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    137. Sreebny L, Chambers MS, Fleming TJ, Martin JW, Toth BB. Xerostomia: managing a complex condition. Interview by Phillip Bonner. Dent Today. 1997 Jan; 16(1):66-7, 86-7. PMID: 9560629.
      Citations: 1     Fields:    Translation:Humans
    138. Williams K, Chambers M, Logan S, Robinson D. Association of common health symptoms with bullying in primary school children. BMJ. 1996 Jul 06; 313(7048):17-9. PMID: 8664762.
      Citations: 52     Fields:    Translation:Humans
    139. Toth BB, Chambers MS, Fleming TC. Prevention and management of oral complications associated with cancer therapies: radiotherapy/chemotherapy. Tex Dent J. 1996 Jun; 113(6):23-9. PMID: 9518843.
      Citations: 2     Fields:    Translation:Humans
    140. Lemon JC, Chambers MS, Wesley PJ, Martin JW. Technique for fabricating a mirror-image prosthetic ear. J Prosthet Dent. 1996 Mar; 75(3):292-3. PMID: 8648577.
      Citations: 8     Fields:    Translation:Humans
    141. Lemon JC, Chambers MS, Wesley PJ, Martin JW. Technique for magnetic placement and orientation of a facial prosthesis. J Prosthet Dent. 1996 Jan; 75(1):50-2. PMID: 8850451.
      Citations:    Fields:    Translation:Humans
    142. Lemon JC, Chambers MS, Wesley PJ, Reece GP, Martin JW. Rehabilitation of a midface defect with reconstructive surgery and facial prosthetics: a case report. Int J Oral Maxillofac Implants. 1996 Jan-Feb; 11(1):101-105. PMID: 8820129.
      Citations: 3     Fields:    Translation:Humans
    143. Chambers MS, Lemon JC, Martin JW, Wesley PJ. A hybrid-mold technique for fabricating facial prostheses. J Prosthet Dent. 1996 Jan; 75(1):53-5. PMID: 8850452.
      Citations: 1     Fields:    Translation:Humans
    144. Lemon JC, Chambers MS, Jacobsen ML, Powers JM. Color stability of facial prostheses. J Prosthet Dent. 1995 Dec; 74(6):613-8. PMID: 8778386.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    145. Toth BB, Chambers MS, Fleming TJ, Lemon JC, Martin JW. Minimizing oral complications of cancer treatment. Oncology (Williston Park). 1995 Sep; 9(9):851-8; discussion 858, 863-6. PMID: 8562326.
      Citations: 4     Fields:    Translation:Humans
    146. King GE, Chambers MS, Martin JW. Patient appointments during interim obturation: is it cost-effective? J Prosthodont. 1995 Sep; 4(3):168-72. PMID: 8603206.
      Citations:    Fields:    Translation:Humans
    147. Chambers MS, Lyzak WA, Martin JW, Lyzak JS, Toth BB. Oral complications associated with aspergillosis in patients with a hematologic malignancy. Presentation and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 May; 79(5):559-63. PMID: 7600217.
      Citations: 4     Fields:    Translation:Humans
    148. Chambers MS, Toth BB, Martin JW, Fleming TJ, Lemon JC. Oral and dental management of the cancer patient: prevention and treatment of complications. Support Care Cancer. 1995 May; 3(3):168-75. PMID: 7655777.
      Citations: 11     Fields:    Translation:Humans
    149. Martin JW, Chambers MS, Lemon JC, Toth BB, Helfrick JF. Prosthodontic and surgical considerations for pediatric patients requiring maxillectomy. Pediatr Dent. 1995 Mar-Apr; 17(2):116-21. PMID: 7603905.
      Citations:    Fields:    Translation:Humans
    150. Chambers MS, Lemon JC. A simple method to maximize use of sticky wax. J Prosthet Dent. 1995 Jan; 73(1):106. PMID: 7699591.
      Citations:    Fields:    
    151. Bradley JD, Flusser D, Katz BP, Schumacher HR, Brandt KD, Chambers MA, Zonay LJ. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J Rheumatol. 1994 May; 21(5):905-11. PMID: 8064733.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    152. Podshadley AG, Chambers MS. A new instrument for placement of self-threading retention pins. J Prosthet Dent. 1994 Apr; 71(4):429. PMID: 8196014.
      Citations:    Fields:    Translation:Humans
    153. Martin JW, Austin JR, Chambers MS, Lemon JC, Toth BB. Postoperative care of the maxillectomy patient. ORL Head Neck Nurs. 1994; 12(3):15-20. PMID: 8564764.
      Citations:    Fields:    Translation:Humans
    154. Tredget EE, Forsyth N, Uji-Friedland A, Chambers M, Ghahary A, Scott PG, Hogg AM, Burke JF. Gas chromatography-mass spectrometry determination of 18O2 in 18O-labelled 4-hydroxyproline for measurement of collagen synthesis and intracellular degradation. J Chromatogr. 1993 Jan 29; 612(1):7-19. PMID: 8454705.
      Citations: 1     Fields:    Translation:HumansCells
    155. Taylor EC, Hollingsworth DF, Chambers MA. The diet of the Tristan da Cunha islanders. Br J Nutr. 1966; 20(3):393-411. PMID: 5923618.
      Citations: 1     Fields:    Translation:Humans
    156. Peel strength and interfacial characterization of maxillofacial silicone elastomers bonded to titanium. Dental Materials.
    157. Biofilm on the tracheoesophageal voice prosthesis. European Archives of Oto-Rhino-Laryngology. 1-9.
    158. Osseointegrated implant-based dental rehabilitation in head and neck reconstruction patients. Head and Neck. 38:E321-E327.
    159. Implant-supported and magnet-retained oral-nasal combination prosthesis in a patient with a total rhinectomy and partial maxillectomy due to cancer. Journal of Prosthetic Dentistry.
    160. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature. Scientific Reports. 6.
    161. The multiple oral presentations of multiple myeloma. Supportive Care in Cancer. 22:259-267.
    162. Fabrication of an unconventional bolus-type stent for a combined intraoral/extraoral defect treated with proton radiation therapy. Journal of Prosthetic Dentistry.
    163. Prosthodontic management and treatment considerations for an HIV-positive patient with a nonhealing lesion of the maxilla. International Journal of Prosthodontics. 29:354-356.
    164. Oral mucosal problems in palliative care patients. Journal of Pharmaceutical Care in Pain and Symptom Control. 8:143-161.
    165. Maxillofacial prosthodontic rehabilitation of a patient with oral complications during and after multimodality therapy for the management of oral squamous cell carcinoma. Journal of Prosthetic Dentistry. 113:651-655.
    166. Xerostomia. 185-199.
    167. Proton versus conventional radiotherapy for pediatric salivary gland tumors. Radiotherapy and Oncology.
    168. Oral complications of cancer therapy. 1349-1362.
    169. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncology. 57:1-5.
    170. Porosity of maxillofacial silicone elastomers and microleakage pattern of the commercially pure Ti-silicone elastomer interface after hydrothermal cycling. Journal of Prosthetic Dentistry. 116:937-942.
    CHAMBERS's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (572)
    Explore
    _
    Co-Authors (96)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _